Northwestern's COVID-19 diagnostic. Photo: Northwestern University

A new wearable device is capable of catching early signs and symptoms associated with COVID-19.

Why it matters: With tests still in too-short supply, any device that can clue doctors to an early COVID-19 case is welcome. And the combination of people staying home because of social distancing and the overwhelming threat of the disease makes home diagnostics even more important.

How it works: The experimental wearable device, which sits at the base of a patient's throat, was developed by researchers at Northwestern University and the Shirley Ryan AbilityLab in Chicago. It was initially meant to monitor speech patterns in stroke victims before it was reengineered for COVID-19, says Northwestern's John Rogers, who led the development.

  • Worn 24/7, the device detects coughing intensity and patterns, along with breathing sounds, heart rate and body temperature. The data is transmitted wirelessly to the cloud, where algorithms provide graphical representations that can be interpreted by physicians.
  • Rogers says about 25 people are currently wearing the devices, a mix of health care workers monitoring themselves for signs of COVID-19 and patients who have been sent home from hospitals and are being monitored remotely.

The new device joins an array of home diagnostics that have become suddenly popular during the pandemic, including pulse oximeters that can measure blood oxygenation levels — a vital sign for COVID-19 patients.

  • "The technology is here to take hospital ICU-grade diagnostics and deliver it to the home, to be worn on the skin for continuous health monitoring," says Rogers. "We think the pandemic will lead to a broader awareness of the value of this monitoring."
  • By one recent count, the market for connected medical diagnostics is expected to grow by an average of 25% a year between now and 2025. With companies like Amazon and Apple increasingly focusing on health diagnostics, "there is a huge opening for tech companies to do more of that work," futurist Amy Webb told me recently.

The bottom line: Health monitoring won't have to wait until your doctor is in.

Go deeper: Diagnostic testing supply shortages threaten coronavirus response

Go deeper

Fauci's guidance on pre-vaccine coronavirus treatments

Illustration: Aïda Amer/Axios

Antibody drugs and various medicine cocktails against the coronavirus are progressing and may provide some relief before vaccines.

The big picture: Everyone wants to know how and when they can return to "normal" life, as vaccines are not expected to be ready for most Americans for at least a year. Two therapies are known to be helpful, and more could be announced by late September, NIAID Director Anthony Fauci tells Axios.

Updated 16 hours ago - Health

World coronavirus updates

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

New Zealand confirmed Thursday there are 13 local cases linked to the four who tested positive for COVID-19, ending 102 days of no community spread. Auckland locked down Wednesday for 72 hours and the rest of NZ is under lesser restrictions.

By the numbers: Over 751,000 people have died of the novel coronavirus globally and another 20.7 million have tested positive, per Johns Hopkins. More than 12.8 million have recovered from the virus.

The pandemic's toll on mental health

Illustration: Aïda Amer/Axios

One in four Americans between 18 and 24 years old say they've considered suicide in the past month because of the pandemic, according to a survey from the Centers of Disease Control and Prevention.

Why it matters: The findings confirm warnings from public health experts about the long-term mental health impacts from the pandemic.